(19)

(11)

EP 3 959 683 A1

(12)

(43) Date of publication: 02.03.2022 Bulletin 2022/09 (21) Application number: 20725358.4 (22) Date of filing: 23.04.2020

(51) International Patent Classification (IPC):  G06T 5/00(2006.01) G06T 7/00(2017.01) (52) Cooperative Patent Classification (CPC): G06T 2207/10108; G06T 2207/30008; G06T 2207/30096; G06T 7/0012; G06T 5/009; G06T 2207/20208; G06T 2207/10104; G06T 2207/20092; G06T 2207/10128 (86) International application number: PCT/US2020/029434 (87) International publication number: WO 2020/219619 (29.10.2020 Gazette 2020/44)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 24.04.2019 US 201962837925 P (71) Applicant: Progenics Pharmaceuticals, Inc. North Billerica, Massachusetts 01862 (US)	(72) Inventor: SJÖSTRAND, Karl Vilhelm North Billerica, Massachusetts 01862 (US) (74) Representative: Graham Watt & Co LLP  St. Botolph's House 7-9 St. Botolph's Road Sevenoaks TN13 3AJ Sevenoaks TN13 3AJ (GB)